Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock Has Average Price Target of $14.06 According to Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received a consensus recommendation of “Moderate Buy” from the twelve analysts that are currently covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $14.06.

A number of brokerages have recently commented on AVAH. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Tuesday. Raymond James Financial upped their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research note on Friday, August 14th. Barclays raised their price objective on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the company an “overweight” rating in a report on Friday, August 28th. JPMorgan Chase & Co. boosted their target price on shares of Aveanna Healthcare from $8.00 to $15.00 and gave the stock a “neutral” rating in a report on Monday, September 14th. Finally, Royal Bank Of Canada upped their price target on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research report on Monday, August 24th.

Insider Buying and Selling

In other Aveanna Healthcare news, CEO Jeff Shaner sold 90,000 shares of Aveanna Healthcare stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $1,035,000.00. Following the transaction, the chief executive officer directly owned 2,561,972 shares of the company’s stock, valued at approximately $29,462,678. The trade was a 3.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Edwin C. Reisz sold 50,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $575,000.00. Following the completion of the sale, the insider owned 1,397,897 shares in the company, valued at $16,075,815.50. This trade represents a 3.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 48,566,081 shares of company stock valued at $558,509,932 over the last quarter. 5.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Aveanna Healthcare

Hedge funds have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd boosted its holdings in Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after acquiring an additional 2,400 shares during the last quarter. Summit Securities Group LLC bought a new position in Aveanna Healthcare during the 1st quarter worth approximately $53,000. C M Bidwell & Associates Ltd. acquired a new position in shares of Aveanna Healthcare in the 2nd quarter worth approximately $69,000. Freestone Grove Partners LP acquired a new position in shares of Aveanna Healthcare in the 2nd quarter worth approximately $73,000. Finally, Landscape Capital Management L.L.C. bought a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at $102,000. 87.96% of the stock is currently owned by institutional investors.

Aveanna Healthcare Stock Up 0.2%

Shares of NASDAQ:AVAH opened at $12.43 on Friday. Aveanna Healthcare has a 52-week low of $5.93 and a 52-week high of $14.71. The company has a market capitalization of $2.71 billion, a PE ratio of 10.11, a price-to-earnings-growth ratio of 0.76 and a beta of 1.95. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. The company has a fifty day moving average of $12.21 and a 200-day moving average of $9.13.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The company had revenue of $670.48 million for the quarter, compared to the consensus estimate of $638.61 million. On average, equities analysts predict that Aveanna Healthcare will post 0.77 EPS for the current fiscal year.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is a diversified healthcare provider focused on delivering medical and supportive care in patients’ homes. The company primarily serves children and adults with complex medical needs, chronic conditions, disabilities, and other circumstances requiring ongoing assistance outside traditional healthcare settings.

Aveanna’s services include private-duty nursing, skilled home health care, hospice and palliative care, personal care, and therapy services.